Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-16
    E.g., 2018-08-16

Articles

51463 items
12:00 AM, Aug 03, 2000  |  BC Extra | Financial News

IPO quartet

Four IPOs began trading on Thursday, as the IPO queue continues to shrink. Knockout mouse company Deltagen (DGEN) raised $105 million its IPO through the sale of 7 million shares at $15. On June 15,...
12:00 AM, Aug 03, 2000  |  BC Extra | Financial News

CombiMatrix raises $36 million

Microarray company CombiMatrix, a subsidiary of Acacia Research (ACRI), raised $36 million through a private equity financing. Investors included Acacia Research; Emerging Growth Management; JDS Capital; Oracle Partners; OrbiMed Advisors; SAC Capital Management; Seneca Capital;...
12:00 AM, Aug 03, 2000  |  BC Extra | Company News

MGI Pharma and MethylGene cancer deal

MOGN gained a North American license from MethylGene (Montreal, Quebec) to MG98, an mRNA inhibitor, and other small molecule inhibitors of DNA methyltransferase, to treat cancer. MOGN will make an equity investment of $6.8 million...
12:00 AM, Aug 02, 2000  |  BC Extra | Company News

Igen and Bayer target POC testing

IGEN and Bayer Diagnostics will explore the development of products for the hospital point-of-care testing market using IGEN's Tricoder diagnostic detection module. BAYG, which is aiming to incorporate time-sensitive tests on a single modular platform,...
12:00 AM, Aug 02, 2000  |  BC Extra | Clinical News

Allos completes Phase II enrollment

ALTH enrolled 50 patients with non-small lung cancer undergoing chemotherapy followed by radiation treatment combined with RSR13, the company's small molecule allosteric hemoglobin modifier radioenhancement agent. The primary end point is response rate of the...
12:00 AM, Aug 02, 2000  |  BC Extra | Company News

Bristol-Myers receives FDA approval

The FDA granted BMY marketing approval for its Glucovance (glyburide plus Glucophage metformin) tablets as first and second line therapy to treat Type II diabetes....
12:00 AM, Aug 02, 2000  |  BC Extra | Company News

DSM to acquire Catalytica's pharmaceutical business

DSM (Heerlen, the Netherlands) will acquire the drug business of Catalytica (CTAL) for $750 million plus the assumption of debt, for a total value of about $800 million. DSM, an integrated group of life science,...
12:00 AM, Aug 02, 2000  |  BC Extra | Clinical News

Scotia reports on Foscan

Scotia (LSE:SOH) released a clinical update of its Foscan photodynamic therapy in head and neck cancer, reporting that tumor was eliminated in 88 percent of evaluable patients at 12 weeks in a 115-patient trial. Complete...
12:00 AM, Aug 02, 2000  |  BC Extra | Clinical News

Cholera bacterium gene sequence reported

Researchers on Tuesday announced the completion of the gene sequence of Vibrio cholerae, the cholera bacterium. Sequencing and assembly of the cholera gene was funded by NIH and was conducted at the Institute for Genomic...
12:00 AM, Aug 02, 2000  |  BC Extra | Company News

Tamiflu submitted in Japan

Gilead partner Roche submitted Tamiflu oseltamivir to the Japanese Ministry for Health and Welfare to gain regulatory approval to treat and prevent influenza A and B infections in adults. Tamiflu received FDA approval for a...

Pages